c Oncogene-induced senescence is a stable proliferative arrest that serves as a tumor-suppressing defense mechanism. p38 mitogen-activated protein kinase (MAPK) has been implicated in oncogene-induced senescence and tumor suppression. However, the specific role of each of the four p38 isoforms in oncogene-induced senescence is not fully understood. Here, we demonstrate that p38␦ mediates oncogene-induced senescence through a p53-and p16INK4A -independent mechanism. Instead, evidence suggests a link between p38␦ and the DNA damage pathways. Moreover, we have discovered a novel mechanism that enhances the expression of p38␦ during senescence. In this mechanism, oncogenic ras induces the Raf-1-MEK-extracellular signal-regulated kinase (ERK) pathway, which, in turn, activates the AP-1 and Ets transcription factors that are bound to the p38␦ promoter, leading to increased transcription of p38␦. These findings indicate that induction of the prosenescent function of p38␦ by oncogenic ras is achieved through 2 mechanisms, transcriptional activation by the Raf-1-MEK-ERK-AP-1/Ets pathway, which increases the cellular concentration of the p38␦ protein, and posttranslational modification by MKK3/6, which stimulates the enzymatic activity of p38␦. In addition, these studies identify the AP-1 and Ets transcription factors as novel signaling components in the senescence-inducing pathway.A lthough aberrant activation of Ras is associated with human tumors, activated ras in early-passage primary human and rodent cells causes permanent growth arrest known as oncogeneinduced senescence (OIS) (1-4). Like apoptosis, OIS is a tumorsuppressing defense mechanism, the disruption of which leads to tumorigenesis (5-10).Multiple signaling intermediates have been identified that play critical roles in the pathways mediating oncogene-induced senescence. The ability of ras to induce senescence depends on activation of the Raf-MEK-extracellular signal-regulated kinase (ERK) mitogen-activated protein kinase (MAPK) pathway (4, 11) and is accompanied by upregulation of p16 INK4A , p53, p14/p19 ARF , and p21 WAF1 (3, 12) and silencing of E2F target genes (13). We previously showed that ras-induced senescence relies on activation of p38, a MAPK previously identified as a major mediator of inflammation and stress responses (14). p38 and its upstream MAPK kinases MKK3 and MKK6 are activated by oncogenic ras as a result of persistent MEK/ERK activation in senescent cells. Constitutive activation of p38 causes premature senescence, whereas inhibition of p38 prevents ras-induced senescence (14). Consistent with the important role of p38 in oncogene-induced senescence and tumor suppression, targeted deletion of p38␣ or PRAK, a downstream substrate kinase of p38, accelerates cancer development in mouse models (10,15,16).p38 MAK has four mammalian isoforms, ␣, , ␦, and ␥, which are encoded by different genes and differ in tissue-specific expression, substrate spectrum, and affinity for upstream MAPK activators (17-23). Our previous data indicated that p38...